|
Jul 28
|
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
|
|
Jul 28
|
Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025
|
|
Jul 24
|
Cannara Secures 5 Key Listings in Québec’s New Vape Cartridge Category Including to be Released Live Rosin Vapes
|
|
Jul 21
|
Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025
|
|
Jun 19
|
Cannara Biotech to Host Investor Webcast on June 25th, 2025
|
|
Jun 18
|
Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year
|
|
Jun 16
|
Aston Bay Holdings And 2 Other TSX Penny Stocks To Watch
|
|
May 27
|
We Ran A Stock Scan For Earnings Growth And Cannara Biotech (CVE:LOVE) Passed With Ease
|
|
Jul 27
|
There's Been No Shortage Of Growth Recently For Cannara Biotech's (CVE:LOVE) Returns On Capital
|
|
Apr 29
|
Cannara Biotech Reports Q2 2024 Financial Results
|
|
Dec 7
|
Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues
|
|
May 4
|
CANARA BIOTECH INC. SECURES AN ADDITIONAL $10 MILLION IN NON-DILUTIVE CAPITAL WITH ITS LEAD CREDIT PROVIDER, BMO COMMERCIAL BANKING
|